COMMUNIQUÉS West-GlobeNewswire

-
Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
05/03/2024 -
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
05/03/2024 -
Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d’administration lors de l’Assemblée générale ordinaire
05/03/2024 -
Rose Hill Leads the Way in Psilocybin Production with Innovative Geo-Thermal Cultivation Enhancements in Jamaica
05/03/2024 -
Beckley Waves Celebrates a Year of Milestones, Including $3.3 Million in New Funding, 200 Retreat Participants, the Inaugural Cohort of Therapist Training, and the Acquisition of Ketamine Therapy Provider Nue Life
05/03/2024 -
Tiny Health, Pioneer of the First At-Home Baby Gut Microbiome Test, Aims to Address the Pediatric Chronic Conditions Crisis
05/03/2024 -
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
05/03/2024 -
LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarkable Growth and Patient Adoption
05/03/2024 -
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
05/03/2024 -
Visory Health Names Ronald McDonald House Charities® of St. Louis As Its First Charity Supporting Children Locally
05/03/2024 -
Er-Kim Selected to Join the World Economic Forum’s New Champions Community
05/03/2024 -
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
05/03/2024 -
Noom Earns Highest CDC Recognition for Diabetes Prevention Program
05/03/2024 -
Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference
05/03/2024 -
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
05/03/2024 -
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal
05/03/2024 -
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
05/03/2024 -
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
05/03/2024 -
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
05/03/2024
Pages